Stockscreener 앱 받기
0.468
1.96%
0.009
시간 외 거래:
.46
-0.008
-1.71%
cbdMD Inc 주식(YCBD)의 최신 뉴스
What Does cbdMD, Inc.'s (YCBD) Latest Move Mean for Cannabis Stocks Investors? - Kalkine Media
Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation - PR Newswire
Why Is cbdMD (NYSE American:YCBD) Buying Twinlab Brand Assets? - Kalkine Media
Cbdmd Stock Price Forecast. Should You Buy YCBD? - StockInvest.us
cbdMD to buy Twinlab as supplement M&A heats up - SupplySide Supplement Journal
YCBD Q2 2026 Earnings: Deep Loss Miss Raises Questions as Shares Fall 3.76%Revenue Growth Outlook - vinanet.vn
cbdMD Q3FY26 sales miss $5.689M estimate; EPS $(0.11) - scanx.trade
Twinlab Assets Acquired by cbdMD Amid Creditor Assignment - The Globe and Mail
cbdMD to Acquire Twinlab's Legacy Supplement Brands - Nutritional Outlook
cbdMD to Acquire Twinlab Brands, Expanding Consumer Wellness Portfolio - citybiz
CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million. - marketscreener.com
cbdMD acquires legacy supplement brand Twinlab - NutraIngredients.com
cbdMD’s Acquisition of Supplement Legacy Brand Twinlab Creates Unique Synergy - WholeFoods Magazine
cbdMD agrees to acquire Twinlab brands - Chain Drug Review
Twinlab Sets Asset Sale to cbdMD for $3.98 Million; Consideration Goes to Akretive - TradingView
cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com Nigeria
cbdMD to acquire Twinlab brands, boosting reven... - Pluang
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness - PR Newswire
cbdMD to Acquire Twinlab Assets; Will Assume $1.75M Debt and Issue 19.9% New Shares - TradingView
YCBD Q2 2026 Earnings: EPS Misses Estimates Sharply, Stock Declines 2.0%Surprise Factor Analysis - dars.gov.et
YCBD | cbdMD, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest ReadingAnalyst Drop Coverage - siam.in
cbdMD Inc (YCBD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
cbdMD Inc (YCBD) Stock News Today - TradingKey
Maxim Group Downgrades CbdMD(YCBD.US) to Hold Rating, Cuts Target Price to $0.5 - Moomoo
YCBD Downgraded by Maxim Group -- Rating Changed to Hold - GuruFocus
Maxim Group Downgrades cbdMD to Hold From Buy - marketscreener.com
Conferencia de resultados del T3 fiscal de 2026 de CBDMD (YCBD): los ingresos aumentan un 20%, objetivo de reducción de costos - TradingKey
YCBD|cbdMD Inc|Price:0.470|Chg%:-0.005 - TradingKey
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... - Yahoo Finance
YCBD Q3 FY2026 earnings call - finance.biggo.com
cbdMD Q3 2026 Earnings Call: Complete Transcript - Benzinga
Earnings call transcript: cbdMD misses Q3 2026 EPS as shares fall after hours - Investing.com
Transcript : CbdMD, Inc., Q3 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
cbdMD Q3 FY2026 Earnings: Revenue Grows 20% as Gross Margin Narrows - TradingKey
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026 - PR Newswire
cbdMD, Inc. (NYSE: YCBD) grows sales to $16.2M amid going concern warning - Stock Titan
cbdMD (NYSE American:YCBD): What Does the Latest Update Mean for Brand Demand? - Kalkine Media
cbdMD Inc (YCBD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
cbdMD schedules conference call on quarterly results - Bitget
cbdMD schedules 4:20 p.m. call to discuss June 30 results - Stock Titan
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results - Yahoo Finance
cbdMD Inc. (YCBD) Holds Steady at $0.58 as Traders Eye Key $0.55–$0.61 RangePercent Below MA - careplusvn.com
CBD Gummy Bears Stock SymbolView gF7h08LSE - Diario AS
Senate bill proposes delay of hemp product restrictions By Investing.com - Investing.com UK
cbdMD Inc. (YCBD) Surges 12% to $0.57: Key Levels to WatchChart Pattern Alerts - dars.gov.et
cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products - TradingView
Cbdmd Cbd Oil Tincture Review: What Customers Are Saying Fall 2026 [WY2QyUdh5WG] - Diario AS
YCBD|cbdMD Inc|Price:0.507|Chg%:+0.034 - TradingKey
cbdMD Inc (YCBD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
cbdMD Inc. (YCBD) Treads Water Near Support Level as Price Ekes Out Slight GainCollar Trade - careplusvn.com
cbdMD Inc. (YCBD) Retreats 3.85% as Stock Tests Key Support LevelsVolume Climax - dars.gov.et
cbdMD Inc (YCBD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
cbdMD Inc (YCBD) Valuation: PE, PB & Fair Value Analysis - TradingKey
cbdMD Inc (YCBD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
I Tried cbdMD’s High Potency THC Gummies—and They Earned the Name - vice.com
cbdMD Inc (YCBD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
YCBD|cbdMD Inc|Price:0.538|Chg%:-0.045 - TradingKey
0.18%
0.69%
자본화:
|
볼륨(24시간):